PALVELLA THERAPEUTICS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

PALVELLA THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $57.98 million for the year ending 2025.

  • PALVELLA THERAPEUTICS, INC. showed a decrease of -30.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from PALVELLA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 17 years of available data (2012 to 2025), PALVELLA THERAPEUTICS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 816.4%.
  • Historical annual values: Fiscal year 2025: $57.98 million | Fiscal year 2024: $83.60 million | Fiscal year 2023: $7.35 million | Fiscal year 2022: $38.64 million | Fiscal year 2021: $117.76 million | Fiscal year 2020: $70.44 million | Fiscal year 2019: $62.26 million | Fiscal year 2018: $74.87 million | Fiscal year 2017: $37.88 million | Fiscal year 2016: $29.36 million | Fiscal year 2015: $29.35 million | Fiscal year 2014: $18.47 million | Fiscal year 2014: $11.1 thousand | Fiscal year 2013: $3.69 million | Fiscal year 2013: $5.2 thousand | Fiscal year 2013: $0.00 | Fiscal year 2012: $6.33 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: